Relationship between advanced glycation end‐products and advanced oxidation protein products in patients with type 2 diabetes with and without albuminuria: A cross‐sectional survey
Open Access
- 29 September 2024
- journal article
- research article
- Published by Wiley in Health Science Reports
- Vol. 7 (10) , e70057
Abstract
Background and Aims: Literature suggests that oxidative stress plays a crucial role in the progression of diabetes. Since poor glycemic control enhances the formation of advanced glycation end‐products (AGEs) and advanced oxidation protein products (AOPP) in individuals with diabetes, exploring the association between glycation and oxidative states in diabetes could also shed light on potential consequences. This study evaluated the effects of albuminuria on AGEs and AOPP levels and measured their relationship in participants with type 2 diabetes (T2D) with or without albuminuria.Methods: A cross‐sectional, matched case‐control study was designed, including 38 T2D subjects with albuminuria and 38 matched T2D subjects with normoalbuminuria. Patients were matched by their body mass index (BMI), age, and duration of diabetes. The unadjusted and adjusted correlation between AGEs and AOPP in the studied groups were analyzed by multiple logistic regression. Using ggplot2, the ties between these two biochemical factors in cases and controls were plotted.Results: This study elucidated a significant association between AGEs and AOPP in participants with normoalbuminuria (r = 0.331, p‐value < 0.05), which continued to be significant after controlling for BMI, age, systolic blood pressure (SBP), and diastolic blood pressure (DBP) (r = 0.355, p‐value < 0.05). However, there was no significant association between AGEs and AOPP in those with albuminuria in the unadjusted model (r = 0.034, p‐value = 0.841) or after controlling for BMI, age, SBP, and DBP (r = 0.076, p‐value = 0.685).Conclusion: Oxidation and glycation molecular biomarkers were correlated in patients without albuminuria; however, this association was not observed in those with albuminuria.Keywords
This publication has 62 references indexed in Scilit:
- Nonlinear systems in medicine.2003
- Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitusPhysiological Research, 2002
- Diabetes and mass spectrometryDiabetes/Metabolism Research and Reviews, 2001
- The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetesMass Spectrometry Reviews, 2000
- Cytokines, Chaos, and ComplexityImmunity, 1999
- Advanced glycation end product (AGE): Characterization of the products from the reaction between D-glucose and serum albuminJournal of Clinical Laboratory Analysis, 1996
- The Possible Control of Chaos in Chronic InflammationClinical Rheumatology, 1996
- Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.Journal of Clinical Investigation, 1994
- Specific glycation of albumin depends on its half-lifeClinical Chemistry, 1993
- Reaction of Monosaccharides with Proteins: Possible Evolutionary SignificanceScience, 1981